Concepedia

Publication | Open Access

Efficacy of the anti–IL-6 receptor antibody tocilizumab in neuromyelitis optica

296

Citations

7

References

2014

Year

Abstract

This study provides Class IV evidence that in patients with NMO, TCZ reduces relapse rate, neuropathic pain, and fatigue.

References

YearCitations

Page 1